OIG Focus On Oxygen Claims
In Oct 2024, the OIG announced that it is focusing on Medicare payments to DME suppliers for oxygen and oxygen equipment.
Resmed Acquires VirtuOx
Medtrade exhibitor Resmed has acquired Medtrade exhibitor VirtuOx, an independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions.
Arrangements With Sleep Labs: Pitfalls To Avoid
If some patients are covered by Medicare, suppliers need to be aware of the federal laws governing such arrangements.
Resmed Launches New Home Sleep Apnea Test
Medtrade exhibitor Resmed has launched NightOwl™, a new home sleep apnea test.
Study: CPAP Reduces Risk Of Death In People With OSA
New meta-analysis demonstrates that CPAP therapy significantly reduces the risk of death for people with obstructive sleep apnea (OSA).
Resmed Unveils Unified Brand
Resmed recently introduced a comprehensive brand evolution designed to unify its brand portfolio.